A mutation in the β-myosin rod associated with hypertrophic cardiomyopathy has an unexpected molecular phenotype

Biochemical and Biophysical Research Communications

Volumn 391, Issue 1, 2010, Pages 352-356

  Armel, Thomas Z ^a   Leinwand, Leslie A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cardiac hypertrophy; Hypertrophic cardiomyopathy; Mutation

Indexed keywords

MYOSIN;

ALPHA HELIX; ARTICLE; CIRCULAR DICHROISM; DISEASE ASSOCIATION; HYPERTROPHIC CARDIOMYOPATHY; MUTATION; MYOFILAMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN STRUCTURE; THERMODYNAMICS; THERMOSTABILITY;

AMINO ACID SUBSTITUTION; CARDIOMYOPATHY, HYPERTROPHIC; GLUTAMIC ACID; HUMANS; LYSINE; MUTATION; PHENOTYPE; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY; THERMODYNAMICS; VENTRICULAR MYOSINS;

EID: 72949109318     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.11.062     Document Type: Article

References (14)

1. Maron B.J., Carney K.P., Lever H.M., Lewis J.F., Barac I., Casey S.A., and Sherrid M.V. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 41 (2003) 974-980
2. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
3. Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., and Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary artery risk development in (Young) adults. Circulation 92 (1995) 785-789
4. Van Driest S.L., Jaeger M.A., Ommen S.R., Will M.L., Gersh B.J., Tajik A.J., and Ackerman M.J. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 44 (2004) 602-610
5. Burch M., and Blair E. The inheritance of hypertrophic cardiomyopathy. Pediatr. Cardiol. 20 (1999) 313-316
6. Roberts R., and Sigwart U. New concepts in hypertrophic cardiomyopathies, part I. Circulation 104 (2001) 2113-2116
7. Buvoli M., Hamady M., Leinwand L.A., and Knight R. Bioinformatics assessment of beta-myosin mutations reveals myosin's high sensitivity to mutations. Trends Cardiovasc. Med. 18 (2008) 141-149
8. Armel T.Z., and Leinwand L.A. Mutations at the same amino acid in myosin that cause either skeletal or cardiac myopathy have distinct molecular phenotypes. J. Mol. Cell. Cardiol. (2009) 10.1016/j.yjmcc.2009.10.011
9. Armel T.Z., and Leinwand L.A. Mutations in the beta-myosin rod cause myosin storage myopathy via multiple mechanisms. Proc. Natl. Acad. Sci. USA 106 (2009) 6291-6296
10. Greenfield N.J. Using circular dichroism spectra to estimate protein secondary structure. Nat. Protoc. 1 (2006) 2876-2890
11. Greenfield N.J. Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactions. Nat. Protoc. 1 (2006) 2527-2535
12. Obermann W.M., van der Ven P.F., Steiner F., Weber K., and Furst D.O. Mapping of a myosin-binding domain and a regulatory phosphorylation site in M-protein, a structural protein of the sarcomeric M band. Mol. Biol. Cell 9 (1998) 829-840
13. Flashman E., Watkins H., and Redwood C. Localization of the binding site of the C-terminal domain of cardiac myosin-binding protein-C on the myosin rod. Biochem. J. 401 (2007) 97-102
14. Welikson R.E., and Fischman D.A. The C-terminal IgI domains of myosin-binding proteins C and H (MyBP-C and MyBP-H) are both necessary and sufficient for the intracellular crosslinking of sarcomeric myosin in transfected non-muscle cells. J. Cell Sci. 115 (2002) 3517-3526